Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of a public media event on the use of statins in the French population.
Bezin J, Francis F, Nguyen NV, Robinson P, Blin P, Fourrier-Réglat A, Pariente A, Moore N. Bezin J, et al. Among authors: robinson p. Arch Cardiovasc Dis. 2017 Feb;110(2):91-98. doi: 10.1016/j.acvd.2016.05.002. Epub 2016 Jul 26. Arch Cardiovasc Dis. 2017. PMID: 27473579 Free article.
When patients report diseases that prescribers seem unaware of: discordance between patient and physician reporting of risk-related previous history in NSAID users from the CADEUS study.
Fourrier-Réglat A, Lacoin L, Pariente A, Lassalle R, Robinson P, Droz-Perroteau C, Bégaud B, Blin P, Moore ND. Fourrier-Réglat A, et al. Among authors: robinson p. Clin Pharmacol Ther. 2010 Nov;88(5):668-75. doi: 10.1038/clpt.2010.166. Epub 2010 Sep 22. Clin Pharmacol Ther. 2010. PMID: 20861835
Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials.
Salvo F, Fourrier-Réglat A, Bazin F, Robinson P, Riera-Guardia N, Haag M, Caputi AP, Moore N, Sturkenboom MC, Pariente A; Investigators of Safety of Non-Steroidal Anti-Inflammatory Drugs: SOS Project. Salvo F, et al. Among authors: robinson p. Clin Pharmacol Ther. 2011 Jun;89(6):855-66. doi: 10.1038/clpt.2011.45. Epub 2011 Apr 6. Clin Pharmacol Ther. 2011. PMID: 21471964 Review.
The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.
Droz-Perroteau C, Dureau-Pournin C, Vespignani H, Marchal C, Blin P, Blazejewski S, Pollet C, Jové J, Robinson P, Moore N, Fourrier-Réglat A; EULEV Study Group. Droz-Perroteau C, et al. Among authors: robinson p. Br J Clin Pharmacol. 2011 Jan;71(1):121-7. doi: 10.1111/j.1365-2125.2010.03805.x. Br J Clin Pharmacol. 2011. PMID: 21143508 Free PMC article.
Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
Droz-Perroteau C, Marchal C, Dureau-Pournin C, Lassalle R, Jové J, Robinson P, Lavernhe G, Vespignani H, Moore N, Fourrier-Réglat A; Eulev Study Group. Droz-Perroteau C, et al. Among authors: robinson p. Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1183-9. doi: 10.1002/pds.3338. Epub 2012 Sep 13. Pharmacoepidemiol Drug Saf. 2012. PMID: 22972760
Continuation rates of levetiracetam in children from the EULEVp cohort study.
Dureau-Pournin C, Pédespan JM, Droz-Perroteau C, Lavernhe G, Mann M, Pollet C, Robinson P, Jové J, Moore N, Fourrier-Réglat A; EULEV study group. Dureau-Pournin C, et al. Among authors: robinson p. Eur J Paediatr Neurol. 2014 Jan;18(1):19-24. doi: 10.1016/j.ejpn.2013.07.003. Epub 2013 Sep 10. Eur J Paediatr Neurol. 2014. PMID: 24035600
4,465 results